Objective. To identify features of ambulatory care associated with reduced hospitalization among drug users with acquired immunodeficiency syndrome (AIDS). Methods. A nonconcurrent prospective study of hospital use by 1,369 drug users with AIDS was conducted using data from New York State Medicaid research data files linked to telephone interview data from directors of ambulatory care clinics serving this group. Results. Follow-up averaged 29 months, during which 88% of subjects were hospitalized at least once. On average, those hospitalized spent 14% of follow-up time as inpatients. Hospitalization was less likely for patients in clinics with case managers (adjusted odds ratio = 0.42, 95% confidence interval 0.25, 0.69) or high director's rating of coordination of care (adjusted odds ratio = 0.50, 95% confidence interval 0.29, 0.89). Multivariate analysis showed significantly less time in hospital for patients in clinics with methadone maintenance, case managers, high continuity ratings, and clinic physicians attending for hospitalized clinic patients. Conclusions. Drug users with AIDS rely heavily on inpatient care, but those followed in clinics featuring greater coordination and offering special services, including methadone treatment and case management, appear to have significantly less hospital use.
INTRODUCTION
The costs of caring for persons with AIDS are driven in large part by the amount of time spent in the hospital. 1 Among persons with acquired immunodeficiency NEWSGHAFFER ET AL.
syndrome (AIDS), those who use illicit drugs use significantly more inpatient services than non-drug users. 2 Drug users have been reported to spend 2 to 3 weeks longer in hospital than non-drug users in the interval between AIDS diagnosis and death. 3 Both health care and social factors underlie drug users' dependence on inpatient services. Because substance abuse treatment and medical care are usually delivered at separate sites, drug users' ambulatory care has been notoriously disjointed. 4 This lack of coordination and accessibility may, in turn, lead to deficiencies in preventive care and delays in the diagnosis and treatment of complications related to human immunodeficiency virus (HIV). s Social factors such as homelessness and absence of involved family or friends may also contribute to increased reliance on hospital care for conditions that might have been managed out of hospital had adequate social supports been present. 6
In this study, we identify features of ambulatory clinic care associated with reduced inpatient utilization among drug users with AIDS enrolled in the New
York State Medicaid program. Our analysis focuses on a broad array of medical, substance abuse, and social services that we hypothesized might affect hospital utilization by addressing problems in coordination, comprehensiveness, and accessibility of medical care or social support deficits in this population. Telephone interviews with 179 (91%) clinic medical directors or their designates were conducted from December 1993 to April 1994. Respondents were asked about clinic setting (i.e., hospital or freestanding), specialty, and the proportions of HIV-infected patients and all clinic patients who were enrolled in Medicaid.
Survey items also pertained to the following five dimensions of care: HIV/AIDS medical services (9 items); drug treatment services (4 items); social support services (6 items); mental health services (3 items); and service access and coordination (10 items). Details of the survey have been described previously. 9
STUDY POPULATION
Approximately 17,000 individuals with AIDS diagnoses had data available in the Medicaid HIV/AIDS Data Base for their mid-AIDS interval. The mid-AIDS interval as defined in previous work 3 excludes the 3 months after AIDS diagnosis and, among decedents, 2 months prior to the month of death. This is a logical period in the natural history of AIDS to examine associations between primary care and hospital use because there is variation in hospital utilization during this time, while utilization in the diagnostic and predeath intervals is consistently high. 3
Subjects were included in the study population only if (1) they had a usual source of care, and their usual care provider was one of the clinics responding to the study survey; (2) they had a history of drug abuse; and (3) they survived at least 1 year after their AIDS diagnosis. Of the initial 17,000 individuals, 54% had a usual source of care during the mid-AIDS interval. Of those, 75% (6, 820) had a usual care provider that responded to the survey. From these, 2,346 with a history of illicit drug use were identified. Of these illicit drug users, we studied 1,369 subjects who survived at least 1 year after AIDS diagnosis (i.e., at least 9 months into their mid-AIDS interval), to allow sufficient time under the care of a provider to influence inpatient utilization, and who had no more than a 3-month gap in their Medicaid enrollment. Persons with enrollment gaps of 3 months or less were included because Medicaid generally covers services delivered over short periods of discontinuous enrollment (Peter Gallagher, NYS Office of Medicaid Management, oral communication, November 1996).
STUDY VARIABLE5
Hospital Utilization. We identified patients with any hospitalization in the mid-AIDS interval. Among those with at least one inpatient stay, we determined the proportion of all eligible mid-AIDS interval days spent in hospital.
Clinic Service Availability. Clinic directors reported the availability and initiation dates of specific services within the aforementioned five dimensions of care in their clinics. These data were used to determine if a particular service was available during each patient's mid-AIDS interval.
Clinic Service Ratings. Each medical director rated his or her clinic's performance on various dimensions of care according to a Likert-type scale. Ratings of specific clinic services on 10-point scales (with a high rating indicating better performance) were divided by tertile into "low," "medium," and "high." Because these ratings did not have smooth distributions, tertiles were approximated with cut points set to make the middle group the largest category.
Clinic AIDS Experience. For each study patient, we determined the cumulative number of Medicaid enrollees with AIDS managed by his or her clinic from 1986 through the date of his or her AIDS diagnosis. Cut points for this measure were based on the quartiles of the distribution in the patient population, forming four groups (0-10, 11-35, 36-80, and >80 patients). Therefore, the HIV experience measure reflects cumulative experience in serving Medicaid-enrolled AIDS populations. However, the majority of HIV/AIDS patients cared for in study clinics were enrolled in Medicaid (median 85%). Medical and Psychiatric Comorbidity. We used Medicaid claims to identify persons with a history of common chronic diseases unlikely to be related to HIV infection (e.g., diabetes mellitus, asthma, emphysema, hypertension, coronary artery disease) or psychiatric disease (i.e., anxiety or personality disorder, depression, schizophrenia, or other psychosis).
AIDS Clinical

ANALYTIC METHODS
From logistic regression models, we determined unadjusted associations of all independent variables with hospitalization (yes/no) during the mid-AIDS interval. Among persons with at least one hospitalization, ordinary least squares regression was used to determine unadjusted associations of independent variables with the proportion of time in the mid-AIDS interval spent in hospital.
Stepwise selection methods were used to determine patient characteristics associated with each outcome. These factors were included as background variables in all multivariable models. Next, we estimated separate stepwise models for the clinic variables categorized into five dimensions. A final stepwise model included all clinic characteristics chosen under each dimension. The P-value criteria for entry and retention in stepwise models were 0.10 and 0.15, respectively.
To determine whether associations between clinic characteristics and outcomes shown in the final stepwise models were independent of clinic AIDS experience, this variable was added to each of the final stepwise models.
Finally, because groups of patients were treated by (and clustered within) the same clinic, we refit the final logistic and linear models using a general estimating equation algorithm with the independence working correlation matrix to account 12 for clustering. The standard errors estimated using a general estimating equation did not differ from those generated by standard logistic and linear modeling, so we present P values and confidence intervals from unclustered methods. A twotailed P value less than .05 indicated statistical significance.
RESULTS
For the 1,369 drug users in the study population, we observed an average of 19.7 months eligible follow-up in the mid-AIDS interval. At least one acute-care hospitalization occurred in this time frame for 88% ( Table I ). The average amount of follow-up time spent in hospital for the full study population was 12%. For the 88% having at least one hospital stay, an average of 13.6% of follow-up time was spent as an inpatient. Over 40% of this group spent more than a tenth, and over 10% spent more than a quarter, of their follow-up time as inpatients in acute-care hospitals.
Also shown in Table I , over one-fourth of the study group was female, and the majority lived in New York City. Over half of the group was between 30 and 39 years old when diagnosed with AIDS. Most of the patients were in the Candida, and no or moderately severe complications, such as bacterial pneumonia, within 3 months. In addition, over 25% of study patients had another chronic medical condition, such as hypertension, and 15% had a psychiatric diagnosis.
CLINIC CHARACTERISTICS
As shown in Table II , many clinics had services or programs that were directed specifically toward care of HIV-infected patients. However, compared to the HIV-related services, drug treatment services were much less widely available.
Of social support services, case management was the most commonly available.
Psychiatric services were available in approximately one-third of clinics. Most clinics had features to accommodate acute-care needs.
Of surveyed clinics, 7% were in the highest quartile of cumulative AIDS experience, and these clinics served as the usual sources of care for nearly 25%
of the study population. However, more than half of study patients received care at clinics with the lowest experience. Minimum and maximum cumulative AIDS experience values were 0 and 338, respectively.
CLINIC ATTRIBUTES AND OCCURRENCE OF HOSPITALIZATION
Also shown in Table II In multivariable analyses of the odds of hospitalization (Table III) 
CLINIC ATTRIBUTES AND AMOUNT OF HOSPITALIZATION AMONG THOSE WITH AT LEAST ONE ADMISSION
Returning to Table II , we display bivariate associations between clinic characteristics and the proportion of the mid-AIDS interval spent in hospital for those with at least one inpatient stay. Of the HIV/AIDS-related services, only having a nutritionist was significantly associated with a greater proportion of the mid-AIDS interval spent in hospital. We observed a very strong association between patients being followed in a clinic that also provides methadone treatment and the proportion of the mid-AIDS interval that study drug users spent as inpatients.
The presence of a case manager was associated with nearly a 3% drop in the proportion of the mid-AIDS interval in hospital.
Appointments within 48 hours and higher ratings of continuity of HIV care
were respectively associated with nearly 3% and 4% reductions in the proportion of time spent in hospital. Conversely, small but significant increases in the propor- Increased clinic hours since 1986, the presence of on-call physicians, the provision of nutritional services on site, and higher director ratings on availability of HIV/AIDS services were unexpectedly related to higher use of hospital care.
While AIDS severity and comorbidity were controlled in our analysis, clinics with these characteristics may serve patients with more-complex health problems not fully captured by the severity and comorbidity measures we used.
Although we have previously reported that AIDS care experience is associated with longer survival of women, 2~ this analysis did not find a significant adjusted association of this characteristic with hospitalization. Our experience measure is based on total numbers of Medicaid AIDS patients followed at study sites. The median proportion of AIDS patients in study clinics who were enrolled on Medicaid was 85%, and since Medicaid is expected to be more prevalent among drug-using AIDS patients, it is unlikely that we are underestimating by a substantial degree the total number of drug-using AIDS patients followed at these sites.
Larger clinics may be treating patients with more-complex problems and with greater social needs; this was not measured in our study. Alternatively, the AIDS care experience may be a less important factor in preventing hospitalization of drug users than specific features of care that promote adherence and continuity of care.
Several other limitations of this study deserve mention. We did not evaluate actual receipt of specific services by particular patients, only services available from the clinic serving as the usual source of care. Further, not all relevant provider characteristics were considered. For example, with the recent advent of highly active antiretroviral therapy associated with reductions in hospitaliza-tion, 21 provider characteristics that promote use of and compliance with these medications should have significant indirect benefits on hospitalization. We did not examine use of antiretroviral therapy in this analysis; our study time frame preceded the use of these more powerful drug combinations. Although we found a strong association of the availability of methadone treatment with reduced hospitalization, this estimate was imprecise because it was based on few clinics with a relatively small number of subjects. This provocative association should be pursued in other, larger-scale investigations. In addition, certain patient and environmental factors not available for consideration in our analysis were likely to have an impact on hospital use, such as homelessness, 22 imprisonment, and the availability of nursing home beds. Last, we studied only patients who had a usual source of care and who had insurance for care; thus, our results are not generalizable to drug users, who have more fragmented receipt of ambulatory services and no coverage for care.
The strength of this study accrues from the Medicaid population base from which it is drawn, as Medicaid is the dominant payer for persons with AIDS. 23 ' 24 We have augmented the comprehensive data on health care service use available on the HIV/AIDS Medicaid Data Base with detailed information about the specific services offered by over 100 diverse sites of care for drug users with AIDS.
These data point to the benefits of social services such as case management, addiction services such as methadone maintenance, and the maintenance of good provider-patient continuity of care on use of the hospital for care. Relatively small outlays of financial resources toward providing these services may reap substantial benefits in relation to reducing expensive inpatient care for drug users with AIDS. 
